{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T21:08:54Z","timestamp":1771967334356,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gene expression profiling has been vastly used to extract the genes that can predict the clinical outcome in patients with diverse cancers, including diffuse large B-cell lymphoma (DLBCL). With the aid of bioinformatics and computational analysis on gene expression data, various prognostic gene signatures for DLBCL have been recently developed. The major drawback of the previous signatures is their inability to correctly predict survival in external data sets. In other words, they are not reproducible in other datasets. Hence, in this study, we sought to determine the gene(s) that can reproducibly and robustly predict survival in patients with DLBCL. Gene expression data were extracted from 7 datasets containing 1636 patients (GSE10846 [n\u2009=\u2009420], GSE31312 [n\u2009=\u2009470], GSE11318 [n\u2009=\u2009203], GSE32918 [n\u2009=\u2009172], GSE4475 [n\u2009=\u2009123], GSE69051 [n\u2009=\u2009157], and GSE34171 [n\u2009=\u200991]). Genes significantly associated with overall survival were detected using the univariate Cox proportional hazards analysis with a <jats:italic>P<\/jats:italic> value\u2009&lt;\u20090.001 and a false discovery rate (FDR)\u2009&lt;\u20095%. Thereafter, significant genes common between all the datasets were extracted. Additionally, chromosomal aberrations in the corresponding region of the final common gene(s) were evaluated as copy number alterations using the single nucleotide polymorphism (SNP) data of 570 patients with DLBCL (GSE58718 [n\u2009=\u2009242], GSE57277 [n\u2009=\u2009148], and GSE34171 [n\u2009=\u2009180]). Our results indicated that <jats:italic>reticulon family gene 1 (RTN1<\/jats:italic>) was the only gene that met our rigorous pipeline criteria and associated with a favorable clinical outcome in all the datasets (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, FDR\u2009&lt;\u20095%). In the multivariate Cox proportional hazards analysis, this gene remained independent of the routine international prognostic index components (i.e., age, stage, lactate dehydrogenase level, Eastern Cooperative Oncology Group [ECOG] performance status, and number of extranodal sites) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Furthermore, no significant chromosomal aberration was found in the <jats:italic>RTN1<\/jats:italic> genomic region (14q23.1: Start 59,595,976\/End 59,870,966).<\/jats:p>","DOI":"10.1038\/s41598-021-00746-0","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T10:02:49Z","timestamp":1635242569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic efficacy of the RTN1 gene in patients with diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Mohamad","family":"Zamani-Ahmadmahmudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mahdi","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Asadabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"746_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1006\/geno.1997.5175","volume":"51","author":"AJ Roebroek","year":"1998","unstructured":"Roebroek, A. J., Contreras, B., Pauli, I. G. & Van de Ven, W. J. cDNA cloning, genomic organization, and expression of the human RTN2 gene, a member of a gene family encoding reticulons. Genomics 51, 98\u2013106. https:\/\/doi.org\/10.1006\/geno.1997.5175 (1998).","journal-title":"Genomics"},{"key":"746_CR2","doi-asserted-by":"publisher","first-page":"13439","DOI":"10.1016\/S0021-9258(19)38669-7","volume":"268","author":"AJ Roebroek","year":"1993","unstructured":"Roebroek, A. J. et al. Cloning and expression of alternative transcripts of a novel neuroendocrine-specific gene and identification of its 135-kDa translational product. J. Biol. Chem. 268, 13439\u201313447 (1993).","journal-title":"J. Biol. Chem."},{"key":"746_CR3","first-page":"197","volume":"69","author":"NH Senden","year":"1996","unstructured":"Senden, N. H. et al. Neuroendocrine-specific protein C (NSP-C): Subcellular localization and differential expression in relation to NSP-A. Eur. J. Cell Biol. 69, 197\u2013213 (1996).","journal-title":"Eur. J. Cell Biol."},{"key":"746_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/35000226","volume":"403","author":"T GrandPr\u00e9","year":"2000","unstructured":"GrandPr\u00e9, T., Nakamura, F., Vartanian, T. & Strittmatter, S. M. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 403, 439\u2013444. https:\/\/doi.org\/10.1038\/35000226 (2000).","journal-title":"Nature"},{"key":"746_CR5","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1038\/sj.onc.1203948","volume":"19","author":"S Tagami","year":"2000","unstructured":"Tagami, S., Eguchi, Y., Kinoshita, M., Takeda, M. & Tsujimoto, Y. A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 19, 5736\u20135746. https:\/\/doi.org\/10.1038\/sj.onc.1203948 (2000).","journal-title":"Oncogene"},{"key":"746_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s004180050157","volume":"108","author":"N Senden","year":"1997","unstructured":"Senden, N. et al. Neuroendocrine-specific protein (NSP)-reticulons as independent markers for non-small cell lung cancer with neuroendocrine differentiation. An in vitro histochemical study. Histochem. Cell Biol. 108, 155\u2013165 (1997).","journal-title":"Histochem. Cell Biol."},{"key":"746_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/(sici)1096-9896(199705)182:1<13::aid-path804>3.0.co;2-z","volume":"182","author":"NH Senden","year":"1997","unstructured":"Senden, N. H. et al. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers. J. Pathol. 182, 13\u201321. https:\/\/doi.org\/10.1002\/(sici)1096-9896(199705)182:1%3c13::aid-path804%3e3.0.co;2-z (1997).","journal-title":"J. Pathol."},{"key":"746_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503\u2013511. https:\/\/doi.org\/10.1038\/35000501 (2000).","journal-title":"Nature"},{"key":"746_CR9","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJMoa032520","volume":"350","author":"IS Lossos","year":"2004","unstructured":"Lossos, I. S. et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350, 1828\u20131837. https:\/\/doi.org\/10.1056\/NEJMoa032520 (2004).","journal-title":"N. Engl. J. Med."},{"key":"746_CR10","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald, A. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937\u20131947. https:\/\/doi.org\/10.1056\/NEJMoa012914 (2002).","journal-title":"N. Engl. J. Med."},{"key":"746_CR11","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1073\/pnas.1732008100","volume":"100","author":"G Wright","year":"2003","unstructured":"Wright, G. et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 100, 9991\u20139996. https:\/\/doi.org\/10.1073\/pnas.1732008100 (2003).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"746_CR12","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz, G. et al. Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359, 2313\u20132323. https:\/\/doi.org\/10.1056\/NEJMoa0802885 (2008).","journal-title":"N. Engl. J. Med."},{"key":"746_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm0102-68","volume":"8","author":"MA Shipp","year":"2002","unstructured":"Shipp, M. A. et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8, 68\u201374. https:\/\/doi.org\/10.1038\/nm0102-68 (2002).","journal-title":"Nat. Med."},{"key":"746_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48721-0","author":"M Zamani-Ahmadmahmudi","year":"2019","unstructured":"Zamani-Ahmadmahmudi, M. & Nassiri, S. M. Development of a reproducible prognostic gene signature to predict the clinical outcome in patients with diffuse large B-cell lymphoma. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-019-48721-0 (2019).","journal-title":"Sci. Rep."},{"key":"746_CR15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1182\/blood-2011-03-345272","volume":"118","author":"AA Alizadeh","year":"2011","unstructured":"Alizadeh, A. A. et al. Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood 118, 1350\u20131358. https:\/\/doi.org\/10.1182\/blood-2011-03-345272 (2011).","journal-title":"Blood"},{"key":"746_CR16","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/bioinformatics\/btn374","volume":"24","author":"B Haibe-Kains","year":"2008","unstructured":"Haibe-Kains, B., Desmedt, C., Sotiriou, C. & Bontempi, G. A comparative study of survival models for breast cancer prognostication based on microarray data: Does a single gene beat them all?. Bioinformatics (Oxford, England) 24, 2200\u20132208. https:\/\/doi.org\/10.1093\/bioinformatics\/btn374 (2008).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"746_CR17","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.18632\/oncotarget.3343","volume":"6","author":"J Chen","year":"2015","unstructured":"Chen, J. et al. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma. Oncotarget 6, 5597\u20135614. https:\/\/doi.org\/10.18632\/oncotarget.3343 (2015).","journal-title":"Oncotarget"},{"key":"746_CR18","first-page":"3860","volume":"63","author":"F Di Sano","year":"2003","unstructured":"Di Sano, F. et al. Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells. Can. Res. 63, 3860\u20133865 (2003).","journal-title":"Can. Res."},{"key":"746_CR19","first-page":"4769","volume":"54","author":"HJ van de Velde","year":"1994","unstructured":"van de Velde, H. J. et al. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis. Can. Res. 54, 4769\u20134776 (1994).","journal-title":"Can. Res."},{"key":"746_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.canlet.2009.01.035","volume":"279","author":"JT Lee","year":"2009","unstructured":"Lee, J. T., Lee, T.-J., Kim, C.-H., Kim, N.-S. & Kwon, T. K. Over-expression of reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Cancer Lett. 279, 185\u2013192. https:\/\/doi.org\/10.1016\/j.canlet.2009.01.035 (2009).","journal-title":"Cancer Lett."},{"key":"746_CR21","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/bioinformatics\/btq282","volume":"26","author":"A Floratos","year":"2010","unstructured":"Floratos, A., Smith, K., Ji, Z., Watkinson, J. & Califano, A. geWorkbench: An open source platform for integrative genomics. Bioinformatics 26, 1779\u20131780. https:\/\/doi.org\/10.1093\/bioinformatics\/btq282 (2010).","journal-title":"Bioinformatics"},{"key":"746_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bjh.12045","volume":"159","author":"SL Barrans","year":"2012","unstructured":"Barrans, S. L. et al. Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome. Br. J. Haematol. 159, 441\u2013453. https:\/\/doi.org\/10.1111\/bjh.12045 (2012).","journal-title":"Br. J. Haematol."},{"key":"746_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/bjh.16744","volume":"192","author":"M Zamani-Ahmadmahmudi","year":"2021","unstructured":"Zamani-Ahmadmahmudi, M., Nassiri, S. M. & Soltaninezhad, F. Development of an RNA sequencing-based prognostic gene signature in multiple myeloma. Br. J. Haematol. 192, 310\u2013321. https:\/\/doi.org\/10.1111\/bjh.16744 (2021).","journal-title":"Br. J. Haematol."},{"key":"746_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.trsl.2017.05.001","volume":"185","author":"M Zamani-Ahmadmahmudi","year":"2017","unstructured":"Zamani-Ahmadmahmudi, M., Dabiri, S. & Nadimi, N. Identification of pathway-based prognostic gene signatures in patients with multiple myeloma. Transl. Res.: J. Lab. Clin. Med. 185, 47\u201357. https:\/\/doi.org\/10.1016\/j.trsl.2017.05.001 (2017).","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"key":"746_CR25","doi-asserted-by":"publisher","first-page":"20560","DOI":"10.1038\/s41598-020-76603-3","volume":"10","author":"J Goedhart","year":"2020","unstructured":"Goedhart, J. & Luijsterburg, M. S. VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots. Sci. Rep. 10, 20560. https:\/\/doi.org\/10.1038\/s41598-020-76603-3 (2020).","journal-title":"Sci. Rep."},{"key":"746_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1182\/blood-2014-05-577189","volume":"125","author":"LH Sehn","year":"2015","unstructured":"Sehn, L. H. & Gascoyne, R. D. Diffuse large B-cell lymphoma: Optimizing outcome in the context of clinical and biologic heterogeneity. Blood 125, 22\u201332. https:\/\/doi.org\/10.1182\/blood-2014-05-577189 (2015).","journal-title":"Blood"},{"key":"746_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood-2016-12-759621","volume":"130","author":"N Tsuyama","year":"2017","unstructured":"Tsuyama, N. et al. BCL2 expression in DLBCL: Reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation. Blood 130, 489\u2013500. https:\/\/doi.org\/10.1182\/blood-2016-12-759621 (2017).","journal-title":"Blood"},{"key":"746_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/jco.2005.03.4264","volume":"24","author":"J Iqbal","year":"2006","unstructured":"Iqbal, J. et al. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 24, 961\u2013968. https:\/\/doi.org\/10.1200\/jco.2005.03.4264 (2006).","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"746_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0002-9440(10)63284-1","volume":"165","author":"J Iqbal","year":"2004","unstructured":"Iqbal, J. et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am. J. Pathol. 165, 159\u2013166 (2004).","journal-title":"Am. J. Pathol."},{"key":"746_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1939-165X.2006.tb00134.x","volume":"35","author":"K Papasouliotis","year":"2006","unstructured":"Papasouliotis, K. et al. Comparison of white blood cell differential percentages determined by the in-house LaserCyte hematology analyzer and a manual method. Vet. Clin. Pathol. 35, 295\u2013302 (2006).","journal-title":"Vet. Clin. Pathol."},{"key":"746_CR31","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"746_CR32","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang, K. et al. PennCNV: An integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17, 1665\u20131674. https:\/\/doi.org\/10.1101\/gr.6861907 (2007).","journal-title":"Genome Res."},{"key":"746_CR33","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","volume":"123","author":"A Bouska","year":"2014","unstructured":"Bouska, A. et al. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood 123, 1681\u20131690. https:\/\/doi.org\/10.1182\/blood-2013-05-500595 (2014).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00746-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00746-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00746-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:45:40Z","timestamp":1670085940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00746-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00746-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21098"}}